• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Introduction to O-(1-cyclopropylcyclopropyl)methylhydroxylamine (CAS No. 2228663-71-4)

O-(1-cyclopropylcyclopropyl)methylhydroxylamine, with the CAS number 2228663-71-4, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, characterized by its unique structural framework, has garnered attention due to its potential applications in the development of novel therapeutic agents and biochemical research.

The structural motif of O-(1-cyclopropylcyclopropyl)methylhydroxylamine consists of a hydroxylamine functional group linked to a bulky 1-cyclopropylcyclopropylmethyl moiety. This distinctive arrangement imparts a high degree of steric hindrance, which can be exploited in designing molecules with specific binding properties. The cyclopropyl groups, known for their stability and rigidity, contribute to the compound's overall stability and resistance to metabolic degradation, making it a promising candidate for drug-like molecules.

In recent years, there has been a growing interest in the development of hydroxylamine derivatives as intermediates in the synthesis of pharmacologically active compounds. Hydroxylamine functionalities are frequently incorporated into molecules due to their ability to participate in various chemical reactions, including nucleophilic substitutions and redox processes. The presence of the cyclopropyl group in O-(1-cyclopropylcyclopropyl)methylhydroxylamine enhances its utility by providing a stable scaffold that can be further modified without compromising its integrity.

One of the most compelling aspects of O-(1-cyclopropylcyclopropyl)methylhydroxylamine is its potential role in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with various diseases, including cancer. By designing molecules that specifically target and inhibit kinase activity, researchers aim to develop treatments that can modulate these pathways effectively. The steric bulk provided by the cyclopropyl groups can help optimize binding interactions with kinase active sites, potentially leading to more potent and selective inhibitors.

Recent studies have also explored the use of O-(1-cyclopropylcyclopropyl)methylhydroxylamine as a building block in the synthesis of protease inhibitors. Proteases are another class of enzymes that are essential for numerous biological processes, and their overactivity or underactivity can lead to diseases such as Alzheimer's and HIV/AIDS. The unique structural features of this compound make it an attractive candidate for designing molecules that can interact with protease active sites, thereby inhibiting their activity and alleviating related symptoms.

The synthesis of O-(1-cyclopropylcyclopropyl)methylhydroxylamine involves multi-step organic transformations that highlight the compound's synthetic versatility. The introduction of the cyclopropyl group into the hydroxymethylhydroxylamine backbone requires careful consideration of reaction conditions and reagent selection to ensure high yield and purity. Advances in synthetic methodologies have enabled researchers to access complex structures like this one with increasing efficiency, paving the way for more detailed mechanistic studies and applications.

In conclusion, O-(1-cyclopropylcyclopropyl)methylhydroxylamine (CAS No. 2228663-71-4) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential applications in drug development make it a valuable tool for researchers exploring new therapeutic strategies. As our understanding of biochemical pathways continues to evolve, compounds like this one will play an increasingly important role in the discovery and development of novel medicines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)